Net Loss Per Share Allocable to Common Stockholders - Schedule of Potential Dilutive Shares of Common Stock Excluded from the Computation of the Diluted Net Loss Per Share Allocable to Common Stockholders (Details) - shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Potential common shares | ||
| Total (in shares) | 9,435,224 | 8,204,424 |
| Common stock options and restricted stock units | ||
| Potential common shares | ||
| Total (in shares) | 4,278,679 | 3,047,628 |
| Warrants to purchase common stock | ||
| Potential common shares | ||
| Total (in shares) | 692,272 | 692,523 |
| Preferred stock | Series A Preferred Stock | ||
| Potential common shares | ||
| Total (in shares) | 4,026,346 | 4,026,346 |
| Preferred stock | Series B Preferred Stock | ||
| Potential common shares | ||
| Total (in shares) | 437,927 | 437,927 |